Washington, D.C. - President Donald Trump has once again targeted what he describes as "ridiculous shower restrictions," ...

Kepler Cheuvreux analyst Frederic Renard revised the rating for Klepierre (EPA:LOIM) SA (LI:FP) (OTC: KLPEF), elevating it from Hold to Buy and increasing the price target from EUR31.00 to EUR35.00.

Denny’s plans to open 25 to 40 new restaurants in 2025, with about half of the openings expected from Keke’s. Keke's expansion will include 60% company-operated and 40% franchised locations. The ...

There often seems to be a connection between budget and box office in Hollywood. Almost all of the year's top ten movies have budgets in excess of $200 million. Netflix is an exception.

Pipio offers a wide range of 140+ AI voices and 60+ AI-generated avatars, enhancing the customization and personalization of video content. Pipio stands out in the market due to its user-friendly ...

Refining margins also contracted. Chevron generated $4.4 billion in free cash flow during the quarter, short of the roughly $7.5 billion doled out in the form of dividends and buybacks.

Former NBA star DeMarcus Cousins delivers his finest performance yet for Strong Group Athletics as the Philippine side remains undefeated in three games in the Dubai International Basketball ...

Carlson and Lift Our Voices were outspoken advocates in the passage of that bill. The Federal Trade Commission has proposed banning noncompete clauses, which could affect general NDAs.

Enigma Labs “We’ve received over 100 reports in the past three weeks that mention drones across the US,” Enigma Labs spokesperson Christine Kim said, citing the company’s user-generated ...

President Trump's rollback of Biden-era safety and security measures will speed up generative AI development, but without federal oversight, who will monitor potential issues?

1:53 Canadian musician calls out AI album for using his name without permission A Canadian musician was surprised to find an entire album, generated by AI, linked to his name and profile on music ...

Clinical trials of the first drugs designed with the help of artificial intelligence could commence this year, Google DeepMind CEO Demis Hassabis suggested Tuesday. Speaking on a panel at the World ...